Implications of Epidiolex FDA Approval on Workers' Compensation
4 MIN READ
In June 2018, the Federal Drug Administration (FDA) approved Epidiolex, the first plant-derived cannabinoid medicine in the United States. With several states already moving toward legalization of medical marijuana, this is a major step for the federal government.
How Differences in Claim Age and Population Affect Opioid Trends
1 MIN READ
Management of opioid therapy can be influenced by the types of drugs filled, differing patient populations, and the nature of the injury. Don’t miss our latest video blog where we will review some of the differences that point to the importance of early intervention and identification of long term risk.
Positive Compound Trends Continue in Work Comp
3 MIN READ
Utilization and costs associated with compound medications fell significantly for both managed and unmanaged claims in 2017.
Using Integrated Solutions to Help Improve The Workers Compensation Claim Process
9 MIN READ
From the moment an injury occurs, to the day an injured worker returns to work, the journey a workers’ compensation claim may take is complex, involving numerous parties and diverse jurisdictional requirements.
Overall Opioid Costs and Utilization is Down
1 MIN READ
Overall opioid cost and utilization continue to drop, due in part to market, societal, and regulatory influences, and the trend is expected to continue.
Improving Outcomes in the Face of Natural Disasters
5 MIN READ
Throughout the year, various natural disasters grip the United States, from devastating hurricanes to massive wildfires. In response, many regions often declare states of emergency to provide relief to those affected by the disasters. Beyond the damage to the environment, personal property and most importantly, people, the impact of natural disasters often reverberates throughout the workers’ compensation industry.
Mitchell 2019 mPower Conference
Join us for Mitchell’s annual customer gathering, the Mi